Completed NA INTERVENTIONAL 2-arm NCT00303212

Tele-HF: Yale Heart Failure Telemonitoring Study

A Study of Telemonitoring to Improve Heart Failure Outcomes

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Updated 7 times since 2017 Last updated: Mar 27, 2020 Started: Mar 31, 2006 Primary completion: Jan 31, 2010 Completion: Jul 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00303212, this NA trial focuses on Congestive Heart Failure and remains completed. Sponsored by National Heart, Lung, and Blood Institute (NHLBI), it has been updated 7 times since 2006, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Apr 2020 — Jan 2021 [monthly]

Completed NA

▶ Show 2 earlier versions

Jun 2018 — Apr 2020 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Mar 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Heart, Lung, and Blood Institute (NHLBI)
National Institutes of Health (NIH)
Yale University

Data source: Yale University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Atlanta, United States , Bridgeport, United States , Camden, United States , Cleveland, United States , Dallas, United States , Dayton, United States , Hackensack, United States , Honolulu, United States , Houma, United States , Indianapolis, United States and 19 more locations